BEIJING, Sept. 28, 2021 /PRNewswire/ -- Xiaobai Maimai
Inc. (NASDAQ: HX) ("Xiaobai Maimai", the "Company", or "we"), a
social e-commerce platform in China, today announced that it
plans to enter the radiation oncology services market in the
U.S.
The Company recently established We Health Limited, a subsidiary
based in New York, to tap into the
cancer therapy and radiation oncology business in the U.S. The
Board of Directors (the "Board") has appointed Ms. Yilin (Linda) Wang to be Co-Chief Executive
Officer. Ms. Wang has extensive experience in medical health,
health management and medical technology related
businesses.
Cancer is a leading cause of death worldwide. According to the
World Health Organization (WTO) Global Cancer Observatory, there
were approximately 18 million cancer cases diagnosed worldwide in
2018, and the number of new cancer cases diagnosed annually is
projected to increase to almost 25 million by 2030. As one of the
most common treatments for cancer, radiotherapy has been widely
adopted and has shown steady growth over the years. According
to the WTO, more than 50% of cancer patients require radiotherapy
as part of their cancer care and it is frequently used to treat the
most common types of cancers. Based on the Company's market
research, the management team believes that there are ample
opportunities for radiation oncology centers located on the East
Coast to cater to patients from different ethnicities due to their
healthcare experience and language expertise.
Ms. Yilin (Linda) Wang, Co-Chief
Executive Officer of Xiaobai Maimai, commented, "The Board has
approved the new business plan to enter into the radiation oncology
services market in the U.S. We plan to open radiation oncology
centers on the East Coast and provide personalized consultation,
treatment planning, radiotherapy and related services to patients
with a wide variety of cancers. We believe rising healthcare
expenditures and the growing adoption of radiotherapy will drive
the growth of this market. We aim to provide patients with safe,
high-quality treatment leveraging our advanced radiotherapy
equipment and attentive healthcare services."
About Xiaobai Maimai Inc.
Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai
Inc., ("Xiaobai Maimai" or the "Company"), is a social e-commerce
platform based in Beijing, China.
The Company collaborates with domestic e-commerce platforms and
offers users a wide selection of high-quality and affordable
products on its social e-commerce platform. Leveraging its
cooperation with mainstream e-commerce platforms and online service
marketplaces, the Company continues to generate fast growth for the
business by identifying and introducing cost-efficient products
through its data analytics algorithm and operating system, and
attracts users to its platform with excellent customer service.
Safe Harbor Statement
This announcement contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements are made under the "safe
harbor" provisions of the U.S. Private Securities Litigation Reform
Act of 1995. These statements can be identified by terminology such
as "will," "expects," "anticipates," "future," "intends," "plans,"
"believes," "estimates," "potential," "continue," "ongoing,"
"targets," "guidance" and similar statements. The Company may also
make written or oral forward-looking statements in its periodic
reports to the U.S. Securities and Exchange Commission (the "SEC"),
in its annual report to shareholders, in press releases and other
written materials and in oral statements made by its officers,
directors or employees to third parties. Any statements that are
not historical facts, including statements about the Company's
beliefs and expectations, are forward-looking statements that
involve factors, risks and uncertainties that could cause actual
results to differ materially from those in the forward-looking
statements. Such factors and risks include, but not limited to the
following: risks related to our ability to obtain equipment,
technology, license and talents at satisfactory terms to start the
planned business, if at all; risks regarding the effect of the
COVID-19 pandemic on the Company and the Company's position in a
post-COVID-19 environment; risks related to the Company's ability
to adapt and make the necessary adjustments to compete and operate
effectively; risks related to decisions or changes in governmental
or private insurers' reimbursement levels for our radiotherapy
services or our ability to obtain reimbursement for our
radiotherapy services; risks related to increased competition and
the development of new competing services; the risk that we may be
unable to develop or achieve commercial success for radiotherapy
services in a timely manner, or at all; risks related to regulatory
requirements or enforcement in the United
States and changes in the structure of the healthcare system
or healthcare payment systems; risks related to our ability to
successfully integrate and derive benefits from any technologies
that we license or acquire; risks related to our projections about
our business, results of operations and financial condition; and
risks related to the potential market opportunity for our products
and services. Further information regarding these and other risks,
uncertainties or factors is included in the Company's filings with
the SEC. All information provided in this announcement is current
as of the date of this announcement, and the Company does not
undertake any obligation to update such information, except as
required under applicable law.
For more information, please visit
ir.xiaobaimaimai.com
For investor inquiries, please contact:
The Company
Investor Relations
Ms. Zenabo Ma
Email: ir@xiaobaimaimai.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-10- 5900-1548
E-mail: Eyuan@christensenir.com
In US
Mr. Tip Fleming
Phone: +1-917-412-3333
Email: tfleming@Christensenir.com
View original
content:https://www.prnewswire.com/news-releases/xiaobai-maimai-plans-to-enter-the-us-radiation-oncology-services-market-301386318.html
SOURCE Xiaobai Maimai Inc.